Lab21 signs up unnamed pharma firm for colorectal cancer companion Dx
This article was originally published in Clinica
Executive Summary
UK personalised medicine firm Lab21 has partnered with a "world-leading" pharma company to develop a new companion diagnostic for use in colorectal cancer.